Molecular and epidemiological characteristics of human Puumala and Dobrava-Belgrade hantavirus infections, Germany, 2001 to 2017.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 15 8 2019
pubmed: 15 8 2019
medline: 17 7 2020
Statut: ppublish

Résumé

IntroductionTwo hantavirus species, Puumala (PUUV) and Dobrava-Belgrade (DOBV) virus (genotype Kurkino), are endemic in Germany. Recent PUUV outbreaks raised questions concerning increasing frequency of outbreaks and expansion of PUUV endemic areas.AimsTo describe the epidemiology of human PUUV and DOBV infections in Germany.MethodsWe conducted an observational retrospective study analysing national hantavirus surveillance data notified to the national public health institute and hantavirus nucleotide sequences from patients collected at the national consultation laboratory between 2001 and 2017. Matching molecular sequences with surveillance data, we conducted epidemiological, phylogenetic and phylogeographic analyses.ResultsIn total, 12,148 cases of symptomatic hantavirus infection were notified 2001-17 (mean annual incidence: 0.87/100,000; range: 0.09-3.51). PUUV infections showed a highly variable space-time disease incidence pattern, causing large outbreaks every 2-3 years with peaks in early summer and up to 3,000 annually reported cases. Sex-specific differences in disease presentation were observed. Of 202 PUUV nucleotide sequences obtained from cases, 189 (93.6%) fall into well-supported phylogenetic clusters corresponding to different endemic areas in Germany. DOBV infections caused few, mostly sporadic cases in autumn and winter in the north and east of Germany.ConclusionsThe frequency of PUUV outbreaks increased between 2001 and 2017 but our data does not support the suggested expansion of endemic areas. The epidemiology of PUUV and DOBV-Kurkino infections differs in several aspects. Moreover, the latter are relatively rare and combining efforts and data of several countries to identify risk factors and develop specific recommendations for prevention could be worthwhile.

Identifiants

pubmed: 31411134
doi: 10.2807/1560-7917.ES.2019.24.32.1800675
pmc: PMC6693291
doi:

Substances chimiques

Antibodies, Viral 0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Annu Rev Med. 1999;50:531-45
pubmed: 10073292
Emerg Infect Dis. 2003 Nov;9(11):1395-401
pubmed: 14718081
Bioinformatics. 2004 Jan 22;20(2):289-90
pubmed: 14734327
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Emerg Infect Dis. 2006 May;12(5):838-40
pubmed: 16704849
J Clin Microbiol. 2007 Sep;45(9):3008-14
pubmed: 17626170
Emerg Infect Dis. 2007 Sep;13(9):1364-6
pubmed: 18252110
Emerg Infect Dis. 2008 May;14(5):850-2
pubmed: 18439382
J Clin Virol. 2009 Jan;44(1):99-101
pubmed: 19058998
Int J Health Geogr. 2009 Jan 16;8:1
pubmed: 19149870
J Clin Microbiol. 2009 Dec;47(12):4029-36
pubmed: 19828747
Mol Biol Evol. 2010 Feb;27(2):221-4
pubmed: 19854763
Vector Borne Zoonotic Dis. 2010 Aug;10(6):563-74
pubmed: 19874190
Euro Surveill. 2010 May 20;15(20):null
pubmed: 20504391
Emerg Infect Dis. 2010 Oct;16(10):1584-6
pubmed: 20875284
Euro Surveill. 2011 Sep 08;16(36):null
pubmed: 21924118
Emerg Infect Dis. 2012 Jul;18(7):1180-3
pubmed: 22709722
Emerg Infect Dis. 2012 Sep;18(9):1461-4
pubmed: 22932394
Front Physiol. 2012 Jul 10;3:237
pubmed: 22934002
Zoonoses Public Health. 2013 Nov;60(7):461-77
pubmed: 23176630
Zoonoses Public Health. 2013 Dec;60(8):549-54
pubmed: 23398736
Dtsch Arztebl Int. 2013 Jul;110(27-28):461-7
pubmed: 23964302
Nat Rev Microbiol. 2013 Aug;11(8):539-50
pubmed: 24020072
BMC Infect Dis. 2013 Oct 03;13:457
pubmed: 24090247
Viruses. 2013 Dec 10;5(12):3071-87
pubmed: 24335778
Virus Res. 2014 Jul 17;187:34-42
pubmed: 24406800
Clin Microbiol Infect. 2014 Oct;20(10):O648-55
pubmed: 24438436
Virus Res. 2014 Jul 17;187:55-8
pubmed: 24440318
Virus Res. 2014 Jul 17;187:43-54
pubmed: 24508343
J Infect Dis. 2014 Jul 15;209 Suppl 3:S79-80
pubmed: 24966193
J Clin Virol. 2015 Mar;64:128-36
pubmed: 25453325
Zoonoses Public Health. 2016 Mar;63(2):83-8
pubmed: 26177110
Emerg Infect Dis. 2015 Dec;21(12):2204-8
pubmed: 26584463
BMC Infect Dis. 2016 Nov 14;16(1):675
pubmed: 27842513
Zoonoses Public Health. 2017 Aug;64(5):381-390
pubmed: 27918151
Emerg Infect Dis. 2017 Jan;23(1):83-86
pubmed: 27983499
J Infect Dev Ctries. 2017 Jan 30;11(1):73-80
pubmed: 28141593
Mol Biol Evol. 2017 Sep 1;34(9):2422-2424
pubmed: 28472384
Infect Ecol Epidemiol. 2017 Mar 24;7(1):1287986
pubmed: 28567209
New Phytol. 2017 Jul;215(2):595-608
pubmed: 28631320
Front Microbiol. 2017 Sep 08;8:1721
pubmed: 28943870
Emerg Infect Dis. 2018 Jun;24(6):1099-1102
pubmed: 29774860
Virus Genes. 2018 Oct;54(5):638-646
pubmed: 30047031
Epidemiol Infect. 2018 Oct;146(13):1680-1688
pubmed: 30078384

Auteurs

Mirko Faber (M)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Detlev H Krüger (DH)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, Germany.

Brita Auste (B)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, Germany.

Klaus Stark (K)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Jörg Hofmann (J)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, Germany.
These authors contributed equally and share last authorship.

Sabrina Weiss (S)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, Germany.
These authors contributed equally and share last authorship.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH